News Focus
News Focus
icon url

learningcurve2020

11/26/16 3:15 PM

#85217 RE: md1225 #85185

The wording is a classic example of being just nebulous enough to not have the FDA hammer come down while baiting retail shareholders. It's inappropriate, IMO.

"The UCLA Brain Tumor Program continues to shine as a beacon of hope, carrying a record of patients with brain tumors living longer than patients treated at any other hospital. "

"Our personalized brain cancer vaccine, DCVax, is the first of its kind and is currently in Phase III clinical trials in 46 centers throughout America. It is on the road to FDA approval as well as clinical trials throughout Europe. Using this vaccine, we are harnessing the patient’s immune system, genetics, pathology, brain mapping and a wide database of bioinformatics to optimize.."